A team of highly regarded professionals and thought leaders manage ISCHEM.  Additionally, there is a large body of individuals who fill crucial consulting and advisory roles. Other individuals working on these projects report to organizations with whom ISCHEM has development projects (university medical schools, NIH, and The American Academy of Cardiology) or subcontractors (Bates White & Ballentine and Intelligent Automation Corporation).

Joel T. Huizenga, is President, Chief Executive Officer and Chairman of the Board of Directors.  He holds a Bachelors Degree in Molecular, Cellular and Developmental Biology from the University of Colorado, a Masters Degree in Molecular Biology from State University of New York at Stonybrook, and an MBA from the University of Rochester.  Previous to founding ISCHEM Corporation, Mr. Huizenga worked as Vice President of Marketing and Business Development at Pantox, a start-up company in the diagnostic measurement of antioxidant defense systems.  Prior experience includes Business Development and Market Management of Diagnostic Systems for SmithKline Beckman's Beckman Instruments, and SmithKline Diagnostics and Business Planning for Hyland Therapeutics, a biopharmaceutical division of Baxter.

Beatrice A. Golomb, M.D., Ph.D., is the Executive Vice President of Medicine and Medical Director for ISCHEM.  Dr. Golomb graduated with a Bachelor's Degree in Physics from the University of Southern California, at the age of 19, Summa Cum Laude, with a 4.0, while working for the Jet Propulsion Laboratory. She then received a Ph.D. in Biology from the University of California, San Diego. Her thesis was “Visual Motion Processing: Some Special Properties”. She then received an M.D. from the Medical School at the University of California, San Diego. She was a postdoctoral fellow in the Computational Neurobiology Laboratory at Salk Institute where she continued her scientific work in pattern recognition technology. She then became a Research Associate Professor at the University of Southern California. Concurrently working with the think tank, RAND Corporation (where she remains a consultant with RAND Health), she developed quality of care indicators for cardiovascular conditions; and in addition, investigated and reported on Gulf War Syndrome. (She was appointed by the White House to the Research Advisory Committee on the Gulf War Illnesses, on which she is Scientific Director.) She is currently an Associate Professor in the Department of Medicine and Family and Preventive Medicine, at the University of California, San Diego. She is a staff physician at the V A San Diego Healthcare System. Dr. Golomb has been the Principle Investigator of a large ($5 million), NIH-funded trial, “Statins and Non-cardiovascular Endpoints”. Her scientific research papers and books include all the technologies pertaining to ISCHEM's business focus including Pattern Recognition, Risk-Benefit determination, Heart Disease, and Stroke. Dr. Golomb's work has been featured on numerous television and radio program, and in the major print news media.

Russell Anderson, Ph.D. is the Vice President of Product Development for ISCHEM. Dr. Anderson has BS in Electrical Engineering and Computer Sciences from the University of California, Berkeley and a Ph.D. in Bioengineering from the University of California, San Francisco and Berkeley. Dr. Anderson was previously the Director of Modeling & Analytics at ieWild where he developed predictive models for credit card companies. Previously he was the Director of Modeling for HNC Software where he was the functional manager of a team of seven Ph.D. scientists and senior scientists and built several multimillion dollar predictive products for credit card fraud. Other previous positions include development of biological based prediction products. Included in this category are The Smith Kettlewell Eye Research Institute (in S.F.) University of Northern California, U.C. Berkeley, U.C. Irvine, The Center for Nonlinear Studies, Los Alamos National Laboratories, and Lawrence Livermore National Laboratories. Dr. Anderson is the author of several patents that protect marketed products.

Tom Brotherton, Ph.D. is the Vice President of Information Technology.  Dr. Brotherton has a Bachelors Degree from Cornell University, a Masters Degree from the University of Toronto, and a Ph.D. from the University of Hawaii, all in electrical engineering.  Subsequently, Dr. Brotherton was an Assistant Professor of Information and Computer Sciences at the University of Hawaii.  Dr. Brotherton was the Cheif Scientist for the Intelligent Automation Corporation until it was sold and was previously to that the Chief Scientist for the Intelligent Automation Corporation. For 15 years prior to IAC, Dr. Brotherton worked at Orincon Corporation as a staff scientist and the head of their Intelligent Systems group, where he developed signal and image processing technologies using fuzzy logic and neural networks for sonar, machine condition and fault monitoring.  In his later years at Orincon, Dr. Brotherton converted the use of these non-linear analysis techniques to the field of cardiology.  His publications demonstrate uses of non-linear analysis with echocardiograms and other cardiovascular instrumentation.

Additionally, ISCHEM has assembled a world class Medical Board.  A brief summary of participants follows.

Committee Chairman:
Regression of Heart Disease
Antonio M. Gotto, Jr., M.D.
Dean, Medical College
Cornell University
    
Committee Chairman:
Molecular Biology of Heart Disease
Bradford C. Berk, M.D., Ph.D.
Professor of Medicine
CEO
Medical Center
University of Rochester

Committee Chairman:
Cardiology
David P. Faxon, M.D.
Professor of Medicine
Harvard University

Committee Chairman:
Vulnerable Plaque
Valentine Fuster, MD, Ph.D.
Professor of Medicine / Cardiology
Dean, Mount Sinai School of Medicine
Director, The Zena & Michael Wiener
Cardiovascular Institute
New York, NY

Committee Chairman:
Stroke
Justin A. Zivin, M.D., Ph.D.
Professor of Neurosciences
School of Medicine
University of California, San Diego

Committee Chairman
Non-linear Statistics
Halbert White, Ph.D.
Professor
Economics
University of California, San Diego

Committee Chairman:
Non-linear Computer Analysis    
David Zipser, Ph.D.
Professor
Cognitive Science
University of California, San Diego
    
Committee Chairman:
Laboratory Medicine
Robert F. Labbé, Ph.D.
Professor Emeritus
Laboratory Medicine
University of Washington

Committee Chairman:
Cardiovascular MRI    
Zahi Adel Fayad, Ph.D.
Assistant Professor  
Mount Sinai School of Medicine
New York, NY

Committee Chairman:
Arterial Biology
Juan Jose Badimon, Ph.D., FACC
Associate Professor of Medicine
Mount Sinai School of Medicine
New York, NY